Navigating Esophageal Squamous Cell Cancer From Diagnosis to Treatment

Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment.
Relevant disclosures can be found with the episode show notes on Medscape www.medscape.c.... The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer pubmed.ncbi.nl...
Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-Term Follow-up of a Prospective Randomized Trial (RTOG 85-01). Radiation Therapy Oncology Group pubmed.ncbi.nl...
Definitive Chemoradiotherapy With FOLFOX Versus Fluorouracil and Cisplatin in Patients With Oesophageal Cancer (PRODIGE5/ACCORD17): Final Results of a Randomised, Phase 2/3 Trial pubmed.ncbi.nl...
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study) pubmed.ncbi.nl...
18-Fluorodeoxy-Glucose Positron Emission Computed Tomography as Predictive of Response After Chemoradiation in Oesophageal Cancer Patients pubmed.ncbi.nl...
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer pubmed.ncbi.nl...
Predictive Value of PD-L1 Expression in Response to Immune Checkpoint Inhibitors for Esophageal Cancer Treatment: A Systematic Review and Meta-analysis pubmed.ncbi.nl...
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials pubmed.ncbi.nl...
A Randomized Controlled Phase III Trial Comparing Two Chemotherapy Regimen and Chemoradiotherapy Regimen as Neoadjuvant Treatment for Locally Advanced Esophageal Cancer, JCOG1109 NExT Study ascopubs.org/d...
Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study pubmed.ncbi.nl...
Initial Safety Assessment of the Endoscopically Injected Oncolytic Virus OBP-301 in Medically Inoperable Esophageal Cancer: NRG-GI007 ascopubs.org/d...
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Durvalumab With and After Chemoradiotherapy in Patients With Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma: KUNLUN ascopubs.org/d...
KEYNOTE-975 Study Design: A Phase III Study of Definitive Chemoradiotherapy Plus Pembrolizumab in Patients With Esophageal Carcinoma pubmed.ncbi.nl...
KEYNOTE-590: Phase III Study of First-Line Chemotherapy With or Without Pembrolizumab for Advanced Esophageal Cancer pubmed.ncbi.nl...
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma pubmed.ncbi.nl...